{"id":1529,"date":"2025-01-21T15:24:24","date_gmt":"2025-01-21T13:24:24","guid":{"rendered":"https:\/\/stephenindustries.com\/?p=1529"},"modified":"2025-01-21T15:24:25","modified_gmt":"2025-01-21T13:24:25","slug":"stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development","status":"publish","type":"post","link":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/","title":{"rendered":"Stephen Industries joined Gesynta Pharma AB’s latest financing round to support its non-hormonal endometriosis drug development"},"content":{"rendered":"\n

Stephen Industries is pleased to have participated in Gesynta Pharma’s latest financing round to support the development of a non-hormonal drug candidate for the treatment of endometriosis.

Endometriosis, a painful chronic inflammatory disease that affects the health and quality of life of more than 10% of women of reproductive age.
<\/p>\n\n\n\n

Gesynta Pharma is developing vipoglanstat, a novel non-hormonal drug candidate for the treatment of endometriosis. Vipoglanstat targets mPGES-1, an enzyme upregulated in endometriotic lesions that drives both pain and lesion progression.
<\/p>\n\n\n\n

Learn more at: www.gesynta.se<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Stephen Industries is pleased to have participated in Gesynta Pharma’s latest financing round to support the development of a non-hormonal drug candidate for the treatment of endometriosis. Endometriosis, a painful chronic inflammatory disease that affects the health and quality of life of more than 10% of women of reproductive age. Gesynta Pharma is developing vipoglanstat, a […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1529","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nStephen Industries joined Gesynta Pharma AB's latest financing round to support its non-hormonal endometriosis drug development - Stephen Industries<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stephen Industries joined Gesynta Pharma AB's latest financing round to support its non-hormonal endometriosis drug development - Stephen Industries\" \/>\n<meta property=\"og:description\" content=\"Stephen Industries is pleased to have participated in Gesynta Pharma’s latest financing round to support the development of a non-hormonal drug candidate for the treatment of endometriosis. Endometriosis, a painful chronic inflammatory disease that affects the health and quality of life of more than 10% of women of reproductive age. Gesynta Pharma is developing vipoglanstat, a […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Stephen Industries\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-21T13:24:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-21T13:24:25+00:00\" \/>\n<meta name=\"author\" content=\"Lilli Wikstr\u00f6m\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lilli Wikstr\u00f6m\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\"},\"author\":{\"name\":\"Lilli Wikstr\u00f6m\",\"@id\":\"https:\/\/stephenindustries.com\/en\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095\"},\"headline\":\"Stephen Industries joined Gesynta Pharma AB’s latest financing round to support its non-hormonal endometriosis drug development\",\"datePublished\":\"2025-01-21T13:24:24+00:00\",\"dateModified\":\"2025-01-21T13:24:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\"},\"wordCount\":105,\"publisher\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\",\"url\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\",\"name\":\"Stephen Industries joined Gesynta Pharma AB's latest financing round to support its non-hormonal endometriosis drug development - Stephen Industries\",\"isPartOf\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/#website\"},\"datePublished\":\"2025-01-21T13:24:24+00:00\",\"dateModified\":\"2025-01-21T13:24:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/stephenindustries.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stephen Industries joined Gesynta Pharma AB’s latest financing round to support its non-hormonal endometriosis drug development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stephenindustries.com\/en\/#website\",\"url\":\"https:\/\/stephenindustries.com\/en\/\",\"name\":\"Stephen Industries\",\"description\":\"Creating futures since 1992\",\"publisher\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stephenindustries.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/stephenindustries.com\/en\/#organization\",\"name\":\"Stephen Industries\",\"url\":\"https:\/\/stephenindustries.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stephenindustries.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg\",\"contentUrl\":\"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg\",\"width\":265,\"height\":75,\"caption\":\"Stephen Industries\"},\"image\":{\"@id\":\"https:\/\/stephenindustries.com\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/stephenindustries.com\/en\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095\",\"name\":\"Lilli Wikstr\u00f6m\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stephenindustries.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g\",\"caption\":\"Lilli Wikstr\u00f6m\"},\"sameAs\":[\"http:\/\/stephenindustries.com\"],\"url\":\"https:\/\/stephenindustries.com\/en\/author\/lilli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stephen Industries joined Gesynta Pharma AB's latest financing round to support its non-hormonal endometriosis drug development - Stephen Industries","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Stephen Industries joined Gesynta Pharma AB's latest financing round to support its non-hormonal endometriosis drug development - Stephen Industries","og_description":"Stephen Industries is pleased to have participated in Gesynta Pharma’s latest financing round to support the development of a non-hormonal drug candidate for the treatment of endometriosis. Endometriosis, a painful chronic inflammatory disease that affects the health and quality of life of more than 10% of women of reproductive age. Gesynta Pharma is developing vipoglanstat, a […]","og_url":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/","og_site_name":"Stephen Industries","article_published_time":"2025-01-21T13:24:24+00:00","article_modified_time":"2025-01-21T13:24:25+00:00","author":"Lilli Wikstr\u00f6m","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lilli Wikstr\u00f6m","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/#article","isPartOf":{"@id":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/"},"author":{"name":"Lilli Wikstr\u00f6m","@id":"https:\/\/stephenindustries.com\/en\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095"},"headline":"Stephen Industries joined Gesynta Pharma AB’s latest financing round to support its non-hormonal endometriosis drug development","datePublished":"2025-01-21T13:24:24+00:00","dateModified":"2025-01-21T13:24:25+00:00","mainEntityOfPage":{"@id":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/"},"wordCount":105,"publisher":{"@id":"https:\/\/stephenindustries.com\/en\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/","url":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/","name":"Stephen Industries joined Gesynta Pharma AB's latest financing round to support its non-hormonal endometriosis drug development - Stephen Industries","isPartOf":{"@id":"https:\/\/stephenindustries.com\/en\/#website"},"datePublished":"2025-01-21T13:24:24+00:00","dateModified":"2025-01-21T13:24:25+00:00","breadcrumb":{"@id":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stephenindustries.com\/en\/stephen-industries-joined-gesynta-pharma-abs-latest-financing-round-to-support-its-non-hormonal-endometriosis-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stephenindustries.com\/en\/"},{"@type":"ListItem","position":2,"name":"Stephen Industries joined Gesynta Pharma AB’s latest financing round to support its non-hormonal endometriosis drug development"}]},{"@type":"WebSite","@id":"https:\/\/stephenindustries.com\/en\/#website","url":"https:\/\/stephenindustries.com\/en\/","name":"Stephen Industries","description":"Creating futures since 1992","publisher":{"@id":"https:\/\/stephenindustries.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stephenindustries.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stephenindustries.com\/en\/#organization","name":"Stephen Industries","url":"https:\/\/stephenindustries.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stephenindustries.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg","contentUrl":"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg","width":265,"height":75,"caption":"Stephen Industries"},"image":{"@id":"https:\/\/stephenindustries.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stephenindustries.com\/en\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095","name":"Lilli Wikstr\u00f6m","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stephenindustries.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g","caption":"Lilli Wikstr\u00f6m"},"sameAs":["http:\/\/stephenindustries.com"],"url":"https:\/\/stephenindustries.com\/en\/author\/lilli\/"}]}},"_links":{"self":[{"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/posts\/1529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/comments?post=1529"}],"version-history":[{"count":3,"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/posts\/1529\/revisions"}],"predecessor-version":[{"id":1534,"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/posts\/1529\/revisions\/1534"}],"wp:attachment":[{"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/media?parent=1529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/categories?post=1529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stephenindustries.com\/en\/wp-json\/wp\/v2\/tags?post=1529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}